ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Patagonia Lithium Ltd

Patagonia Lithium Ltd (PL3N)

0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
-
( - )
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

PL3N Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

PL3N - Frequently Asked Questions (FAQ)

What is the current Patagonia Lithium share price?
The current share price of Patagonia Lithium is AUD 0.00
What is the 1 year trading range for Patagonia Lithium share price?
Patagonia Lithium has traded in the range of AUD 0.00 to AUD 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1ADAdAlta Limited
AUD 0.002
(0.00%)
0
14DO1414 Degrees Limited
AUD 0.008
(0.00%)
0
14DN1414 Degrees Limited
AUD 0.00
(0.00%)
0
14D1414 Degrees Limited
AUD 0.019
(0.00%)
0
13S13 Seeds Limited
 0.00
(0.00%)
0
1ADAdAlta Limited
AUD 0.002
(0.00%)
0
14DO1414 Degrees Limited
AUD 0.008
(0.00%)
0
14DN1414 Degrees Limited
AUD 0.00
(0.00%)
0
14D1414 Degrees Limited
AUD 0.019
(0.00%)
0
13S13 Seeds Limited
 0.00
(0.00%)
0
PLLPiedmont Lithium Limited
AUD 0.106
(0.00%)
3.68M
AMCAmcor PLC
AUD 14.694
(0.00%)
1.08M
AMPAMP Limited
AUD 1.46
(0.00%)
278.11k
GGPGreatland Resources Ltd
AUD 6.591
(0.00%)
200.51k
DRODroneShield Limited
AUD 2.922
(0.00%)
200k

Discussion

View Full Feed
LTListener LTListener 2 minutes ago
They must have all the money at the table. No professional presentation or communication!

License, partner or sale!!!
RSPI
monocle monocle 3 minutes ago
Rhetoric from POTUS about annexing our longtime northern allies is fine. Everything is fine.
NB
Stockman1010101 Stockman1010101 4 minutes ago
We are going into the TEENS BABY.
Load Em UP.
FNMA
GetSeriousOK GetSeriousOK 4 minutes ago
Good Grief, $266k R&D is PEANUTS for a developmental biotech. And you're only going back to 2022. So they spent peanuts on R&D in 2022, 2023, 2024. What's your point?

Good grief.

But let's look at your bullet points.* The Company, working with its Chinese manufacturer,
BIEL
Sctrben Sctrben 5 minutes ago
Saw a nice incline since 💪
OBLG
SSKILLZ1 SSKILLZ1 5 minutes ago
Your gonna need him, specifically with Schmidt which I think is a huge injury for the yanks. Even then I think you could use another arm in the rotation, Warren has good stuff so does the kid they called up recently, but in my opinion need another decent rotation piece even with gil in my opinion, t
JerryCampbell JerryCampbell 6 minutes ago
Stop posting AI nonsense and go to the SEC website yourself.

2012 charges filed: https://www.sec.gov/enforcement-litigation/litigation-releases/lr-22510

2018 all charges dismissed: https://www.secactions.com/sec-yorkville-advisors-stipulate-too-dismissal-of-action-again
NWBO
cadillacdave cadillacdave 7 minutes ago
My prediction is Mugabi comes out of retirement, at age 65 and beats all three reigning middleweight champions, by knockout, in the same evening, thereby unifying the WBO, WBC, WBA and IBF titles.

And IONQ goes up this week.
IONQ
zab zab 8 minutes ago
Trump and his clown show, no wonder the world has nothing to do with him.
Stockman1010101 Stockman1010101 8 minutes ago
when was that 18 years ago. Some of the shareholders in FNMA/FMCC were not even born yet.
FMCC
williamssc williamssc 10 minutes ago
We have ongoing long-term use occurring via compassionate use. Safety is well studied.
AVXL
gitreal gitreal 12 minutes ago
It's way, way overdue. It would have been so easy for SEC investigators to nail these crooks to the wall 4 years ago by making them prove there was a Guerrero Mine. Or making them prove they had been paid $82 million in gold and cash. Or making them prove James Gilbert was real. So easy!
AABB
wadegarret wadegarret 12 minutes ago
Hweb- 2025 isn't over yet, plus

it doesn't really matter anyway, as I was only playing with 10% of past gains as of October 2023. What you call my manic style, made me huge profits since 2004. For example, I made 150% in 2004, 100% in 2005, 60% in 2006, lost 50% in 2008, but then
COHR GERN TSSI
blue Hawaii blue Hawaii 12 minutes ago
We've had some amazing news releases in the past few weeks I can't wait to see more Starting hopefully Tomorrw 

good luck 
Ionq for the win Ionx for the kill 
IONQ
BullNBear52 BullNBear52 12 minutes ago
The rabbits we have aren't interested in carrots.
seekinganswers seekinganswers 14 minutes ago
LOL How much did they have to pay???? .... Parties Stipulate to Dismiss Remaining Claims Following Partial Grant of Summary Judgment Motion
Bottom line is they prey on companies that need money and the shareholders always take the beating while the company gets the money and Yorkville get's
NWBO
Penny Grabber Penny Grabber 14 minutes ago
22.7% of LM Funding America shares are held by institutional investors. 36.1% of LM Funding America shares are held by insiders.
LMFA
236T568 236T568 16 minutes ago
More Epstein thingy
https://bsky.app/profile/maxberger.bsky.social/post/3ltslhn4cq22b
nickeli54 nickeli54 17 minutes ago
Looking here because of volume but dang $3M in convertibles? They need an AS of over 12B now. Am I missing anything? 
CGAC
Adjustedtosteep Adjustedtosteep 18 minutes ago
Is this a TX SOS filing?
MVNT
weedtrader420 weedtrader420 20 minutes ago
We’re at 68 on the fear and greed, let’s see how high we can take it
HBARUSD
resx18 resx18 21 minutes ago
Tecarfarin’s unique single-enzyme (CES2) metabolism addresses warfarin’s limitations, reducing bleeding risks and drug interactions. Guidehouse research highlights the economic burden of LVAD patients, with major bleeding events costing up to $54,100 per hospitalization. With the LVAD market project
ABT

Your Recent History

Delayed Upgrade Clock